Clinical Trial Update: Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion [Phase 4]

View source ↗

Summary

A Phase 4 trial compares aspirin plus a potent P2Y12 inhibitor versus aspirin plus clopidogrel in patients undergoing PCI for complex coronary lesions, and recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)
• PoTent P2Y12 Inhibitor

Snippet

Sponsor: Samsung Medical Center | Conditions: Coronary Artery Disease | Phase 4 | Status: RECRUITING